Headquartered in Dublin, OH·Fiscal year ends June·NYSE: CAH·cardinalhealth.com
About Cardinal Health
Cardinal Health is a healthcare services and products company. Its largest business distributes branded, specialty and generic pharmaceuticals.
**Pharmaceutical and Specialty Solutions** is by far its largest segment, generating most of revenue. It serves retail pharmacy chains such as CVS Health, with which it recently signed a binding letter of intent to renew distribution agreements. It also serves hospitals and specialty and physician practices, and operates a generics sourcing program.
**Global Medical Products and Distribution** manufactures and distributes medical and laboratory products, including the Cardinal Health Brand line. The company is running an ongoing improvement plan for this segment.
**Other** consists of three operating segments:
- **Nuclear and Precision Health Solutions:** nuclear pharmacies and manufacturing facilities.
- **at-Home Solutions:** home-health and direct-to-patient products and services. The company is expanding this business through the pending acquisition of AdaptHealth's Diabetes Health business.
- **OptiFreight Logistics:** logistics and freight management.
The company also provides performance and data solutions, including real-world evidence research with pharmaceutical partners such as Eli Lilly. Updated
McKesson set another record high at $1,105.15, topping the mark it just made on Nov. 13. Rival Cardinal Health rose 0.97% while customer CVS Health slipped 0.82%.
Before the movelast 24 hours
Jim Cramer
We just get me into McKesson. Please. Can I just have some Amgen?
Cardinal Health notched a fresh one-year high at $283.87, topping the record it set just three sessions earlier. Peers diverged: UnitedHealth added 1.09% while CVS Health slipped 0.82%.
Now Chief Accounting Officer at CARDINAL HEALTH INC
A new chief accounting officer at the $65.6 billion drug distributor means fresh ownership of the books that govern revenue recognition across one of the largest pharmaceutical supply chains in the US. Her Form 3 starts the clock on future buy and sell disclosures worth tracking.
43 stocks notched fresh 52-week highs this week, with leadership spread across Motorola Solutions, ICICI Bank, Edwards Lifesciences, Coca-Cola, Humana and Fastenal. Motorola Solutions leads at $530.42, 7.7% past its prior peak.
AppLovin opened up 29.5%, the single biggest move across 382 priority names and nearly double the next gainer. The downside is just as wide, with Dutch Bros off 15.1% and four more names down double digits.
Full-year guidance went up to $12.80 to $13.00 per share, and management locked in a binding letter of intent to renew its CVS Health distribution agreements, removing the biggest customer-concentration question hanging over the stock. Pharmaceutical and Specialty Solutions profit rose 17%, the fourth straight quarter of beating EPS expectations.
Earnings · 2027 Q1Jason M. HollarChief Executive Officer, Cardinal Health
“Given this quarter's strong performance and our updated expectations for the remainder of the year, we are raising our fiscal 2027 non-GAAP EPS outlook.
A guidance raise one quarter into fiscal 2027 sets a higher bar for the rest of the year at the $60.7 billion distributor, and it puts pressure on rival wholesalers reporting into the same demand backdrop. Watch how much of the raise management attributes to the quarter versus the back half.
New 52-week high$253.71+2.0% vs prior high · 2026-09-03
Cardinal Health closed at $253.71, a record that clears its early September peak by 2.05% and caps a climb from $154.58 a year ago. The $58.7 billion distributor has now taken out every high set during its spring stall.
Healthcare demand holds up when the economy slows, which makes the sector a natural place for retirees to look for income heading into the new year. The quality of that income varies…
Markets turned south again Wednesday as surging yields and geopolitical fears rattled investors, but Wall Street analysts spotted opportunity and danger in names like Baidu, Klarna, Honeywell Aerospace, and Dollar Tree that…
Kiplinger’s Personal Finance May 2026 letter makes it clear that if you are looking for yield, the door is wide open across the entire risk spectrum. We are seeing a massive spread,…
Roughly a year ago, 24/7 Wall St. ran a piece titled Forget UnitedHealth. Cardinal Health Is the Best Healthcare Stock to Buy Right Now, arguing that Cardinal Health (NYSE: CAH | CAH…
William Blair launched coverage of Cardinal Health (NYSE:CAH | CAH Price Prediction) with an Outperform rating today, framing the pharma distributor as a durable franchise with specialty-led upside. The firm simultaneously initiated…
This morning’s jobs report landed hard. Nonfarm payrolls plunged by 92,000 jobs, shattering expectations of a 55,000 gain. Unemployment climbed to 4.4%, while average hourly earnings jumped 0.4% month-over-month — well above…
Cardinal Health (NYSE: CAH | CAH Price Prediction) delivered a decisive second-quarter beat on February 5, 2026, with non-GAAP EPS of $2.63, surpassing the $2.38 consensus estimate by 10.5%. Revenue climbed 19%…
Cardinal Health (NYSE: CAH | CAH Price Prediction) delivered a commanding first quarter for fiscal 2026, beating both earnings and revenue expectations by wide margins while raising full-year guidance. The stock climbed…
Dividend investing stands out as a reliable path to building wealth because it turns company profits into a steady cash stream for shareholders. Unlike chasing high-growth stocks that can swing wildly with…
Live Updates Tuesday Wrap-up4:05pm ETThe Vanguard S&P 500 ETF closed at 590.16 Tuesday, up almost 1%. Don't Shop Shopify12:14pm ETOn the flip side, Phillip Securities analyst Helena Wang has downgraded Shopify (Nasdaq:…
Lock Them Up and Throw Away the Key Letting go of a losing stock is simple, but clinging to a winner — especially one that’s doubled, tripled, or quadrupled your initial investment…
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) has faced severe headwinds in 2025, with its stock plummeting over 50% from its April high. This decline was driven by a rare first-quarter earnings…
These four Dividend Aristocrats are far outperforming the S&P 500 so far this year. They still offer investors good entry points and may be total return home runs for 2025.
With all of the major indices making solid moves higher in 2024, we were very interested to see what the top prognosticators across Wall Street think is in store for 2025 as…
Cardinal Health is a healthcare services and products company. Its largest business distributes branded, specialty and generic pharmaceuticals. **Pharmaceutical and Specialty Solutions** is by far its largest segment, generating most of revenue.
What is the CAH stock price target?
24/7 Wall St.'s 12-month price target for CAH is $335.40, rated Buy. The Wall Street consensus target is $294.87. CAH price prediction →